Tango Therapeutics (TNGX) News Today → “Retirement Secret” Showed 995% Gain Last Time We Shared It (From Stansberry Research) (Ad) Free TNGX Stock Alerts $7.33 -0.43 (-5.54%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineTango Therapeutics (NASDAQ:TNGX) Stock Price Down 7%marketbeat.com - April 25 at 8:44 PMTango Therapeutics (NASDAQ:TNGX) Trading Down 3.8%americanbankingnews.com - April 21 at 4:58 AMTango Therapeutics (NASDAQ:TNGX) Stock Price Down 3.8%marketbeat.com - April 19 at 1:59 PMTango Therapeutics, Inc. Forecasted to Post Q2 2024 Earnings of ($0.34) Per Share (NASDAQ:TNGX)americanbankingnews.com - April 19 at 2:46 AMTango Therapeutics, Inc. (NASDAQ:TNGX) Expected to Post Q2 2024 Earnings of ($0.34) Per Sharemarketbeat.com - April 18 at 5:59 AMTango Therapeutics, Inc. Expected to Post Q1 2024 Earnings of ($0.33) Per Share (NASDAQ:TNGX)americanbankingnews.com - April 18 at 1:26 AMTango Therapeutics, Inc. Forecasted to Earn Q1 2024 Earnings of ($0.33) Per Share (NASDAQ:TNGX)marketbeat.com - April 17 at 4:47 PMFY2024 Earnings Estimate for Tango Therapeutics, Inc. Issued By Cantor Fitzgerald (NASDAQ:TNGX)marketbeat.com - April 12 at 6:24 AMVanguard Group Inc. Purchases 197,624 Shares of Tango Therapeutics, Inc. (NASDAQ:TNGX)marketbeat.com - April 12 at 4:08 AMTango Therapeutics (NASDAQ:TNGX) Shares Down 3.3% marketbeat.com - April 5 at 2:38 PMTango Therapeutics (NASDAQ:TNGX) Stock Price Up 5.2%marketbeat.com - April 4 at 3:08 PMTango Therapeutics (NASDAQ:TNGX) Earns Overweight Rating from Analysts at Cantor Fitzgeraldmarketbeat.com - April 4 at 8:50 AMTango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)businesswire.com - April 1 at 4:48 PMBuy Rating Affirmed for Tango Therapeutics on Strong Pipeline and Financial Stabilitymarkets.businessinsider.com - March 21 at 11:58 AMQ1 2024 Earnings Forecast for Tango Therapeutics, Inc. Issued By Leerink Partnrs (NASDAQ:TNGX)marketbeat.com - March 21 at 8:01 AMTango Therapeutics (NASDAQ:TNGX) Shares Gap Up After Analyst Upgrademarketbeat.com - March 20 at 10:34 AMTango Therapeutics (NASDAQ:TNGX) PT Raised to $17.00 at HC Wainwrightmarketbeat.com - March 20 at 8:11 AMTango Therapeutics Inc (TNGX) Reports Full Year and Q4 2023 Financial Resultsfinance.yahoo.com - March 20 at 6:57 AMWedbush Reaffirms "Outperform" Rating for Tango Therapeutics (NASDAQ:TNGX)marketbeat.com - March 18 at 6:43 PMTNGX Stock Earnings: Tango Therapeutics Misses EPS, Misses Revenue for Q4 2023investorplace.com - March 18 at 4:11 PMRecap: Tango Therapeutics Q4 Earningsbenzinga.com - March 18 at 2:52 PMTango Therapeutics (NASDAQ:TNGX) Shares Gap Down to $9.03marketbeat.com - March 18 at 11:24 AMTango Therapeutics (NASDAQ:TNGX) Shares Down 6% marketbeat.com - March 12 at 3:37 PMTNGX Aug 2024 20.000 putfinance.yahoo.com - March 11 at 10:26 AMInvesco Ltd. Has $8.72 Million Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)marketbeat.com - March 9 at 4:22 AMAdage Capital Partners GP L.L.C. Increases Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)marketbeat.com - March 8 at 7:19 AMAdage Capital Partners GP L.L.C. Boosts Stake in Tango Therapeutics, Inc. (NASDAQ:TNGX)marketbeat.com - March 8 at 7:19 AMTango Therapeutics to Participate in Upcoming Investor Conferencesbusinesswire.com - March 6 at 7:00 AMTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Charles Schwab Investment Management Inc.marketbeat.com - March 6 at 4:15 AMTango Therapeutics to Highlight Preclinical Data on Precision Oncology Pipeline at the American Association for Cancer Research (AACR) Annual Meeting 2024globenewswire.com - March 5 at 4:47 PMCompanies Like Tango Therapeutics (NASDAQ:TNGX) Are In A Position To Invest In Growthfinance.yahoo.com - March 3 at 9:45 AMTango Therapeutics, Inc. (NASDAQ:TNGX) Shares Purchased by Fmr LLCmarketbeat.com - February 26 at 5:39 AMDekaBank Deutsche Girozentrale Takes Position in Tango Therapeutics, Inc. (NASDAQ:TNGX)marketbeat.com - February 25 at 5:00 AMTNGX Mar 2024 7.500 callfinance.yahoo.com - February 17 at 8:29 PMTNGX Mar 2024 12.500 callfinance.yahoo.com - February 17 at 3:25 PMTango Therapeutics (NASDAQ:TNGX) Shares Gap Up to $12.41marketbeat.com - February 12 at 11:45 AMTango Therapeutics, Inc. to Post Q1 2024 Earnings of ($0.30) Per Share, Leerink Partnrs Forecasts (NASDAQ:TNGX)marketbeat.com - February 7 at 8:05 AMTango Therapeutics to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conferencefinance.yahoo.com - January 31 at 8:49 AMTango Therapeutics Must Produce Its Own Data To Justify Its Valuationseekingalpha.com - January 7 at 6:09 AMAnalysts Are Bullish on These Healthcare Stocks: Tango Therapeutics (TNGX), Esperion (ESPR)markets.businessinsider.com - January 4 at 8:41 AMMedivir´s licensee, Tango Therapeutics, has dosed the first patient with TNG348, a novel USP1 inhibitor, in a phase 1/2 clinical studyfinance.yahoo.com - January 4 at 8:41 AMTango Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of TNG348 in Patients with BRCA1/2-Mutant and Other HRD+ Cancersfinance.yahoo.com - January 3 at 9:53 AMSubdued Growth No Barrier To Tango Therapeutics, Inc. (NASDAQ:TNGX) With Shares Advancing 25%finance.yahoo.com - December 13 at 8:42 AMB. Riley Securities Initiates Coverage of Tango Therapeutics (TNGX) with Buy Recommendationmsn.com - December 8 at 10:41 PMTango Therapeutics initiated with a Buy at B. Rileyrealmoney.thestreet.com - December 8 at 5:41 PMWall Street Analysts Predict an 110.53% Upside in Tango Therapeutics, Inc. (TNGX): Here's What You Should Knowfinance.yahoo.com - December 8 at 12:40 PMHow Much Upside is Left in Tango Therapeutics, Inc. (TNGX)? Wall Street Analysts Think 115.31%finance.yahoo.com - November 13 at 3:36 PMTango Therapeutics to Highlight Preclinical Data on PRMT5 Inhibitors at the Society for Neuro-Oncology (SNO) 28th Annual Meetingfinance.yahoo.com - November 13 at 10:36 AMPositive Outlook for Tango Therapeutics: Comprehensive Analysis of Ongoing Clinical Trials and Promising PRMT5 Inhibitorsmarkets.businessinsider.com - November 10 at 7:19 PMPositive Financial Performance and Promising Drug Development Bolster Tango Therapeutics’ Buy Ratingmarkets.businessinsider.com - November 10 at 4:18 AM Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address “Retirement Secret” Showed 995% Gain Last Time We Shared It (Ad)Central Banks Buying Gold in Record Numbers Most folks have completely missed the fact that the world's Central Banks have been quietly gobbling up as much gold as they can… Stacking it in their locked vaults on pallets in record numbers. Find out why right here (and see what you can do to get in too with just a few dollars). TNGX Media Mentions By Week TNGX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TNGX News Sentiment▼1.050.41▲Average Medical News Sentiment TNGX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TNGX Articles This Week▼42▲TNGX Articles Average Week Get Tango Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TNGX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SPRY News Today ELVN News Today ARQT News Today ETNB News Today TYRA News Today OPK News Today IMNM News Today SAGE News Today ALXO News Today SAVA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TNGX) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tango Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
